Status
Conditions
About
In experimental and clinical settings it has been shown that transplant tolerance is possible. It has been suggested that regulatory T cells play a beneficial role in the establishment of tolerance. Calcineurin inhibitors may inhibit development of regulatory T cells. However, the influence of calcineurin inhibitors on markers of transplant tolerance has not been studied in patients undergoing liver transplantation. Currently the investigators conduct a study to evaluate the safety and efficacy of a calcineurin inhibitor free immunosuppression in patients undergoing liver transplantation. In this study measurements of immune function and CD4+CD25high-Foxp3+-Il2/CD8+ status will also be performed. In parallel these measurements should be compared to a group of patients undergoing standard immunosuppression including calcineurin inhibitors.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
58 participants in 2 patient groups
Loading...
Central trial contact
Aiman Obed, Prof. Dr.; Armin D Goralczyk, Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal